Safety and Efficacy of Sofwave Treatment to Lift Lax Skin
Launched by SOFWAVE MEDICAL LTD · Mar 30, 2021
Trial Information
Current as of June 24, 2025
Completed
Keywords
ClinConnect Summary
This study is a two-arm study. Eligible patients will receive 2-4 face and/or neck and/or submental or "off the face" (abdomen, or arms, or thighs, or Décolleté) treatments (per PI discretion, 2-12 weeks apart) using the Sofwave System. In arm 1, each investigational site would treat the full face and/or neck and/or submental zones including 1. -The forehead and temples (left and right including the peri orbital zone) to lift the eyebrows 2. The cheeks (left and right including perioral zone and nasolabial folds) 3. Submental and sides of the neck (left and right) to lift lax skin. In arm 2...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Healthy female and male subjects between the ages 35-80.
- • 2. Non-Smoker.
- • 3. Fitzpatrick skin type I-VI.
- • 4. Desire to lift lax skin in the neck and submental and/or to lift the brows.
- • 5. Able and willing to comply with all visit, treatment and evaluation schedules and requirements.
- • 6. Able to understand and provide written Informed Consent
- • 7. Women of child-bearing age are required to be using a reliable method of birth control at least 3 months prior to study enrollment.
- Exclusion Criteria:
- • 1. Pregnant or planning to become pregnant, having given birth less than 3 months ago, and/or breast feeding.
- • 2. Presence of any active systemic or local infections.
- • 3. Presence of active local skin disease that may alter wound healing.
- • 4. Severe solar elastosis.
- • 5. History of smoking in past 10 years.
- • 6. History of chronic drug or alcohol abuse.
- • 7. Excessive subcutaneous fat on the cheeks.
- • 8. Significant scarring in the area to be treated.
- • 9. Severe or cystic facial acne, acutance uses during past 6 months.
- • 10. Presence of a metal stent or implant in the facial area (dental implants and/or braces are not excluded).
- • 11. Inability to understand the protocol or to give informed consent.
- • 12. History of cosmetic treatments in the facial area to be treated, including facial skin-tightening procedure within the 6 months ; injectable (Botox or fillers) of any type within the 6 months; ablative or non-ablative resurfacing/rejuvenation laser treatment or light treatment within the past 6 months, dermabrasion or deep facial peels within the past 12 months; facelift, blepharoplasty, or brow lift (including contour threads) within the past 12 months.
- • 13. Taking Isotretinoin or other oral retinoid within the past 6 months; taking anti-platelet or anti-coagulant within the past 2 weeks.
- • 14. As per the investigator's discretion, any physical or mental condition which might make it unsafe for the subject to participate in this study.
About Sofwave Medical Ltd
Sofwave Medical Ltd. is an innovative medical technology company specializing in non-invasive aesthetic solutions. With a commitment to advancing skin rejuvenation and tightening, Sofwave leverages its proprietary Synchronous Ultrasound Parallel Beam Technology (SUPERB™) to deliver effective treatments that enhance patient outcomes with minimal downtime. The company is dedicated to conducting rigorous clinical trials that validate the safety and efficacy of its products, while continually striving to improve the patient experience and expand its portfolio of advanced therapeutic options in the field of dermatology and aesthetic medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nashville, Tennessee, United States
Nashville, Tennessee, United States
Hackensack, New Jersey, United States
Virginia Beach, Virginia, United States
Patients applied
Trial Officials
Ruthie Amir, MD
Study Director
Sofwave
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials